Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
|
Dibrompropamidine isethionate 0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
|
Dibrompropamidine isetionate 1.5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
|
Dibromopropamidine isethionate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
|
Dibromopropamidine isethionate |
Is a |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
|
Dibrompropamidine isethionate 0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
|
Dibrompropamidine isetionate 1.5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
|
Product containing dibrompropamidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
1 |
Product containing dibrompropamidine in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
|
Product containing dibrompropamidine in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
|
Product containing calamine and dibrompropamidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
2 |
Dibrompropamidine isetionate |
Is a |
False |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
|
Product containing dibrompropamidine and undecylenic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
2 |
Dibrompropamidine isetionate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
|
Product containing dibrompropamidine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
1 |
Product containing dibrompropamidine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
1 |
Allergy to dibrompropamidine |
Causative agent (attribute) |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
1 |
Product containing only calamine and dibrompropamidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
2 |
Product containing only dibrompropamidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
1 |
Product containing only dibrompropamidine and undecylenic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
2 |
Dibrompropamidine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
1 |
Product containing only dibrompropamidine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dibrompropamidine (substance) |
Inferred relationship |
Some |
1 |